Application Due Date: February 15 th 2019
Because 2011, Ashoka– among the world’s biggest networks of social business owners and Boehringer Ingelheim— a family-owned world leading and research-driven Pharmaceutical business, have actually worked together to develop and grow the worldwide effort– Making More Health (MMH).
Making More Health unites the very best experience in social development and worldwide health care to enhance health-care gain access to for individuals, animals and their neighborhoods around the globe.
The MMH Accelerator is a structured, 11- month service accelerator program used under the MMH Effort that supports social business owners with reputable start-ups in the health area with a chance to enhance and scale their work by means of the reach and operations of an international health care business through co-creation.
Through the MMH Accelerator, individuals are offered with customized access to knowledge and capability structure to open their next stage of development. A distinct function of the program is its co-creation method — which includes getting involved social business owners working together with Boehringer Ingelheim workers to collaboratively create and carry out pertinent interventions. At the end of the accelerator, social business owners with effective interventions will have the chance to provide their services to Boehringer Ingelheim’s management group in addition to social financiers to draw in more financial investment.
Social business owners with reputable start-ups in the human.
( non- contagious illness) or animal health area are motivated to.
use, if their companies fulfill the following requirements;
# Late phase start-ups (a minimum of 2 years of ages) in human health (non-communicable illness) or animal health.
# Completely signed up legal entity that is at least 2 years of ages.
# Post earnings with an item, clients and sales.
# Developed with a workplace, group, standard systems and procedures in location.
# Running in Kenya, Ghana or Nigeria.
# Open to deal with a pharmaceutical business such as Boehringer Ingelheim in a co-creation method.
# Capability to devote a full-time resource( s) to carry out MMH Accelerator activities.
# Possible to develop shared-value through co-creation
# Disruptive capacity of development
# Strategic suitable for Boehringer Ingelheim
1. Trainings (both virtual and in-person) on service development and scaling techniques, financier engagement and pitching, customized to the tactical requirements of your company.
2. Access to technical knowledge
( in-person) in financing, technique, operations, info innovation,.
marketing and social investing to name a few to assist you.
address tactical capability spaces particular to your company.
3. Access to tactical networks
consisting of: social financiers, leading social business owners in the health.
care area and executive employee from Boehringer Ingelheim and.
4. Financing of as much as Euros 50 k in money plus extra in-kind knowledge valued at Euros 100 k.
5. Financier engagement assistance consisting of preparation of financier engagement products and helped with access to financiers.
Action (********** ) Timeline
Due date for application 15 th February, 2019
Round one interviews 11 th Jan–28 th February,2019
Due Diligence (********************************** ) th February–16 th March,2019
Panel Interviews 28 th March, 2019
Admission 8th April, (********************** )